Citigroup’s Vascular Solutions Inc VASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-164,837
| Closed | -$9.25M | – | 7516 |
|
|
2016
Q4 | $9.25M | Buy |
164,837
+153,813
| +1,395% | +$7.84M | 0.01% | 1256 |
|
|
2016
Q3 | $532K | Buy |
11,024
+6,269
| +132% | +$292K | ﹤0.01% | 3843 |
|
|
2016
Q2 | $198K | Sell |
4,755
-8,138
| -63% | -$303K | ﹤0.01% | 4509 |
|
|
2016
Q1 | $419K | Buy |
12,893
+11,786
| +1,065% | +$340K | ﹤0.01% | 4322 |
|
|
2015
Q4 | $38K | Buy |
1,107
+4
| +0.4% | +$136 | ﹤0.01% | 6137 |
|
|
2015
Q3 | $36K | Buy |
1,103
+825
| +297% | +$29.6K | ﹤0.01% | 5651 |
|
|
2015
Q2 | $10K | Buy |
278
+12
| +5% | +$391 | ﹤0.01% | 6489 |
|
|
2015
Q1 | $8K | Sell |
266
-2,674
| -91% | -$76.8K | ﹤0.01% | 6578 |
|
|
2014
Q4 | $80K | Buy |
2,940
+2,333
| +384% | +$63.3K | ﹤0.01% | 5395 |
|
|
2014
Q3 | $15K | Buy |
607
+462
| +319% | +$11K | ﹤0.01% | 6073 |
|
|
2014
Q2 | $3K | Sell |
145
-2,455
| -94% | -$53.7K | ﹤0.01% | 6685 |
|
|
2014
Q1 | $68K | Sell |
2,600
-2,695
| -51% | -$67.1K | ﹤0.01% | 5292 |
|
|
2013
Q4 | $122K | Buy |
5,295
+4,763
| +895% | +$93.3K | ﹤0.01% | 5089 |
|
|
2013
Q3 | $9K | Buy |
532
+336
| +171% | +$5.44K | ﹤0.01% | 6265 |
|
|
2013
Q2 | $3K | Buy |
+196
| New | +$3.08K | ﹤0.01% | 6481 |
|
Other funds holding VASC
Citigroup's VASC Position: Q1 2017 in Review
Citigroup sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 164,837 shares — an estimated $9.25M sold.
Citigroup first reported a position in VASC in Q2 2013 and held it in 15 quarters. The position peaked at $9.25M in Q4 2016. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.
- Citigroup reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
- Citigroup sold 164,837 Vascular Solutions Inc shares in Q1 2017, an estimated $9.25M.
- Citigroup first reported a position in Vascular Solutions Inc in Q2 2013 and held it in 15 quarters.
- Citigroup's Vascular Solutions Inc position peaked at $9.25M in Q4 2016.
- 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.
Based on Citigroup's 13F filing for Q1 2017, filed 12 May 2017.